scholarly journals Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality

2013 ◽  
Vol 73 (8) ◽  
pp. 2435-2444 ◽  
Author(s):  
Suresh Kalathil ◽  
Amit A. Lugade ◽  
Austin Miller ◽  
Renuka Iyer ◽  
Yasmin Thanavala
2012 ◽  
Vol 93 (3) ◽  
pp. 272-282 ◽  
Author(s):  
Hong-Shiue Chou ◽  
Ching-Chuan Hsieh ◽  
Ronald Charles ◽  
Lianfu Wang ◽  
Timothy Wagner ◽  
...  

2015 ◽  
Vol 5 (2) ◽  
pp. e1062208 ◽  
Author(s):  
Astrid Olsnes Kittang ◽  
Shahram Kordasti ◽  
Kristoffer Evebø Sand ◽  
Benedetta Costantini ◽  
Anne Marijn Kramer ◽  
...  

Nephron ◽  
2021 ◽  
pp. 1-11
Author(s):  
Jiawei Ji ◽  
Yuan Zhuang ◽  
Zhemin Lin ◽  
Yihang Jiang ◽  
Wei Wang ◽  
...  

<b><i>Objective:</i></b> Myeloid-derived suppressor cells (MDSCs) are heterogeneous cells which can suppress T-cell functionality. Herein, we evaluated the functional importance of MDSCs in the context of kidney ischemia-reperfusion injury (IRI) and explored their ability to regulate innate and adaptive immune cell function in this context. <b><i>Methods:</i></b> The differentiation of MDSCs was induced in vitro by treating cells with GM-CSF and interferon (IFN)-γ. In a murine model of renal IRI, serum creatinine and blood urea nitrogen values were measured to monitor kidney function, while histopathological and immunohistochemical approaches were used to assess kidney injury severity. In addition, flow cytometry was employed to assess the phenotypes and apoptosis of kidney cells in these mice. <b><i>Results:</i></b> MDSCs induced by treatment with GM-CSF + IFN-γ could suppress T-cell functionality in vitro<i>.</i> The adoptive transfer of these MDSCs into an IRI mouse model system enhanced kidney damage and impaired renal function following the recruitment of these cells to renal tissues in these mice. Following such adoptive transfer, the relative frequency of MDSCs with a CD11b<sup>+</sup>Ly6G<sup>−</sup>Ly6C<sup>high</sup> monocytic-MDSC phenotype decreased, whereas cells with a CD11b<sup>+</sup>Ly6G<sup>+</sup>Ly6C<sup>low</sup> polymorphonuclear-MDSC phenotype become more prevalent within kidney tissues following IRI. Adoptive transfer also coincided with increased frequencies of macrophages and dendritic cells (DCs) in the kidney tissues. This suggested that M-MDSCs contributed to early-stage renal IRI damage by differentiating into these deleterious cell types. However, MDSC-induced suppression of CD4<sup>+</sup> and CD8<sup>+</sup> T-cell infiltration was not sufficient to prevent the deterioration of renal function in these mice. <b><i>Conclusions:</i></b> Herein, we successfully developed a protocol wherein MDSCs were differentiated in vitro through combination GM-CSF/IFN-γ treatment. When these MDSCs were subsequently adoptively transferred into a murine model of renal IRI, they aggravated kidney damage, likely owing to the differentiation of M-MDSCs into deleterious macrophages and DCs.


2016 ◽  
Vol 2016 ◽  
pp. 1-17 ◽  
Author(s):  
Irina Lyadova Vladimirovna ◽  
Ekaterina Sosunova ◽  
Alexander Nikolaev ◽  
Tatiana Nenasheva

To protect host against immune-mediated damage, immune responses are tightly regulated. The regulation of immune responses is mediated by various populations of mature immune cells, such as T regulatory cells and B regulatory cells, but also by immature cells of different origins. In this review, we discuss regulatory properties and mechanisms whereby two distinct populations of immature cells, mesenchymal stem cells, and myeloid derived suppressor cells mediate immune regulation, focusing on their similarities, discrepancies, and potential clinical applications.


2018 ◽  
Vol 36 (5_suppl) ◽  
pp. 38-38
Author(s):  
Xing Li ◽  
Xiang-yuan Wu ◽  
Nan Jiang ◽  
Yan-Fang Xing ◽  
Jie Chen ◽  
...  

38 Background: A recent study indicated that Lectin-type oxidized LDL receptor-1 (LOX-1) was a distinct surface marker for human polymorphonuclears myeloid-derived suppressor cells (PMN-MDSC). The present study was aimed to investigate the existence LOX-1 PMN-MDSC in hepatocellular carcinoma (HCC) patients, the latent mechanism and their association with clinical parameters. Methods: 30 HCC patients and 30 health control were included. LOX-1+CD15+ PMN-MDSCs were investigated. Results: LOX-1+CD15+ PMN-MDSC were significantly elevated in both WB and PBMC of HCC patients compared with healthy control. LOX-1+CD15+ PMN-MDSC were more abundant in PBMC than WB. Addition of PMN-MDSCs resulted in significantly reduced proliferation and IFN-γ production of T cells with a dosage dependent manner. LOX-1-CD15+ PMNs present no suppressive function. The suppression on T cell proliferation and IFN-γ production was reversed by ROS inhibitor and Arginase inhibitor. ROS level of LOX-1+CD15+ PMN by DCFDA were higher in LOX-1+CD15+ PMN-MDSCs than LOX-1-CD15+ PMNs, as well as the mRNA levels of the NADPH oxidase NOX2. Meanwhile, the expression of arginase I and activity of arginase were also significantly raised in LOX-1+CD15+ PMN-MDSCs. LOX-1+CD15+ PMN-MDSCs displayed significantly higher expression of spliced X-box–binding protein 1 (sXBP1), ATF3 and CCAAT/enhancer binding protein (CHOP) were higher. For HCC patients, LOX-1+CD15+ PMN-MDSCs in WB were positively related to Cancer of the Liver Italian Program (CLIP) score. Conclusions: LOX-1+CD15+ PMN-MDSC were elevated in HCC patients and suppressed T cell proliferation through ROS/Arg I pathway with ER stress as a potential feature. LOX-1+CD15+ PMN-MDSC presented positive association with the prognosis of HCC patients.


2019 ◽  
Author(s):  
Μαρία Τσιρογιάννη

Στην παρούσα προοπτική μελέτη εκτιμήθηκε η συσχέτιση μεταξύ της ΝΚ κυτταροτοξικής δραστικότητας, των Μυελικών Κατασταλτικών κυττάρων (Myeloid Derived Suppressor cells - MDSCs) και των Τ-ρυθμιστικών κυττάρων (T-Regulatory cells – Tregs), ως προς τη διάρκεια της ανταπόκρισης και την ολική επιβίωση, ασθενών πασχόντων απο υψηλού κινδύνου Μυελοδυσπλαστικό σύνδρομο (ΜΔΣ) ή ολιγοβλαστική Οξεία Μυελογενή Λευχαιμία (ΟΜΛ) που λάμβαναν θεραπεία με τον υπομεθυλιωτικό παράγοντα 5-Αζασυτιδίνη. Ο απώτερος σκοπός της μελέτης ήταν η αναγνώριση πρώϊμων βιοδεικτών με προγνωστική σημασία ως προς την συνολική ανταπόκριση των ασθενών αυτών στη χορηγούμενη θεραπεία.Οι ασθενείς που συμμετείχαν στην παρούσα μελέτη είχαν ήδη λάβει τουλάχιστον τρείς κύκλους θεραπείας με τον υπομεθυλιωτικό παράγοντα 5-Αζασυτιδίνη. Η in vitro προσδιορισμένη ΝΚ-κυτταροτοξικότητα σε αυτή την ομάδα των ασθενών έχει προγνωστική αξία ως προς τη διάρκεια της ανταπόκρισης και ως προς την ολική επιβίωση, οι ασθενείς που επιδείκνυαν υψηλή ΝΚ-κυτταροτοξικότητα παρουσίαζαν μακρύτερη επιβίωση και μακρύτερη διάρκεια ανταπόκρισης σε σύγκριση με τους ασθενείς που επιδείκνυαν χαμηλή ΝΚ-κυτταροτοξικότητα. Οι πληθυσμοί των ανοσορρυθμιστικών κυττάρων MDSCs και Tregs στο περιφερικό αίμα ασθενών μετα βραχεία έκθεση σε 5-Αζασυτιδίνη, δε διέφεραν στατιστικώς σημαντικά σε σύγκριση με τον πληθυσμό των υγιών μαρτύρων.Σύμφωνα με τα αποτελέσματα της μελέτης μας, η θεραπευτική δράση της 5-Αζασυτιδίνης διενεργείται, τουλάχιστον μερικώς, μέσω ανοσορρυθμιστικής επίδρασης του παράγοντα αυτού. Με βάση την πρόσφατη αναζήτηση της βιβλιογραφίας, η μελέτη αυτή αποτελεί την πρώτη δημοσιευμένη μελέτη που καταγράφει θετική συσχέτιση μεταξύ της ΝΚ-κυτταροτοξικότητας και της ολικής επιβίωσης ασθενών υπο 5-Αζασυτιδίνη.


Sign in / Sign up

Export Citation Format

Share Document